Global gene expression profiling of Plasmodium falciparum in response to the anti-malarial drug pyronaridine

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Kritsiriwuthinan, Kanyanan ^a,b   Shaw, Philip J ^a   Wongsombat, Chayaphat ^a   Chavalitshewinkoon Petmitr, Porntip ^b   Kamchonwongpaisan, Sumalee ^a  

^a NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chloroquine; gene expression; microarray; Plasmodium falciparum; Pyronaridine

Indexed keywords

CHLOROQUINE; DNA; PYRONARIDINE; ANTIMALARIAL AGENT; NAPHTHYRIDINE DERIVATIVE;

ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DNA MICROARRAY; DNA TRANSCRIPTION; DRUG EXPOSURE; DRUG MECHANISM; GENE EXPRESSION PROFILING; IC 50; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; SCHIZONT; TREATMENT RESPONSE; TROPHOZOITE; DRUG EFFECT; GENETICS; HUMAN; MICROARRAY ANALYSIS; PHYSIOLOGICAL STRESS; TIME;

ANTIMALARIALS; GENE EXPRESSION PROFILING; HUMANS; INHIBITORY CONCENTRATION 50; MICROARRAY ANALYSIS; NAPHTHYRIDINES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMODIUM FALCIPARUM; STRESS, PHYSIOLOGICAL; TIME FACTORS;

EID: 80051800859     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-242     Document Type: Article

References (50)

1. World Malaria Report 2010. http://www.who.int/malaria/world-malaria- report-2010/en/index.html
2. Antimalarial drugs: modes of action and mechanisms of parasite resistance. Muller IB, Hyde JE, Future Microbiol 2010 5 1857 1873 10.2217/fmb.10.136 21155666
3. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
4. Synthesis of new antimalarial drug pyronaridine and its analogues (author's transl). Zheng XY, Chen C, Gao FH, Zhu PE, Guo HZ, Yao Xue Xue Bao 1982 17 118 125 7102320
5. [Synthesis of 7351, a new antimalarial drug (author's transl)]. Zheng XY, Xia Y, Gao FH, Chen C, Yao Xue Xue Bao 1979 14 736 737 554435
6. Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro. Elueze EI, Croft SL, Warhurst DC, J Antimicrob Chemother 1996 37 511 518 10.1093/jac/37.3.511 9182108 (Pubitemid 26116966)
7. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays. Kurth F, Pongratz P, Belard S, Mordmuller B, Kremsner PG, Ramharter M, Malar J 2009 8 79 10.1186/1475-2875-8-79 19389221
8. Gametocytocidal activity of pyronaridine and DNA topoisomerase II inhibitors against multidrug-resistant Plasmodium falciparum in vitro. Chavalitshewinkoon-Petmitr P, Pongvilairat G, Auparakkitanon S, Wilairat P, Parasitol Int 2000 48 275 280 10.1016/S1383-5769(99)00028-8 10725690 (Pubitemid 30145444)
9. Improved assessment of Plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay. Druilhe P, Brasseur P, Blanc C, Makler M, Antimicrob Agents Chemother 2007 51 2112 2116 10.1128/AAC.01385-06 17387158 (Pubitemid 46903102)
10. Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections. Ringwald P, Bickii J, Same-Ekobo A, Basco LK, Antimicrob Agents Chemother 1997 41 2317 2319 9333075 (Pubitemid 27422240)
11. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, Bustos DG, Tjitra E, Bedu-Addo G, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L, Lancet 2010 375 1457 1467 10.1016/S0140-6736(10)60322-4 20417857
12. Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro. Chavalitshewinkoon P, Wilairat P, Gamage S, Denny W, Figgitt D, Ralph R, Antimicrob Agents Chemother 1993 37 403 406 8384810 (Pubitemid 23072580)
13. Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum. Auparakkitanon S, Wilairat P, Biochem Biophys Res Commun 2000 269 406 409 10.1006/bbrc.2000.2305 10708566 (Pubitemid 30440313)
14. Targeting of hematin by the antimalarial pyronaridine. Auparakkitanon S, Chapoomram S, Kuaha K, Chirachariyavej T, Wilairat P, Antimicrob Agents Chemother 2006 50 2197 2200 10.1128/AAC.00119-06 16723583 (Pubitemid 43807543)
15. The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus. Kawai S, Kano S, Chang C, Suzuki M, Am J Trop Med Hyg 1996 55 223 229 8780465 (Pubitemid 26299211)
16. PlasmoDB: a functional genomic database for malaria parasites. Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, Gao X, Gingle A, Grant G, Harb OS, Heiges M, Innamorato F, Iodice J, Kissinger JC, Kraemer E, Li W, Miller JA, Nayak V, Pennington C, Pinney DF, Roos DS, Ross C, Stoeckert CJ Jr, Treatman C, Wang H, Nucleic Acids Res 2009 37 539 543 10.1093/nar/gkn814 18957442
17. Making Arrays. http://derisilab.ucsf.edu/data/microarray/software.html
18. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675 10.1126/science.781840 781840
19. Synchronization of Plasmodium falciparum erythrocytic stages in culture. Lambros C, Vanderberg JP, J Parasitol 1979 65 418 420 10.2307/3280287 383936 (Pubitemid 10222999)
20. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, Antimicrob Agents Chemother 1979 16 710 718 394674 (Pubitemid 10082023)
21. Microarray Image Analysis ScanAlyze Download. http://rana.lbl.gov/ EisenSoftware.htm
22. Characterization of human malaria parasite Plasmodium falciparum eIF4E homologue and mRNA 5' cap status. Shaw PJ, Ponmee N, Karoonuthaisiri N, Kamchonwongpaisan S, Yuthavong Y, Mol Biochem Parasitol 2007 155 146 155 10.1016/j.molbiopara.2007.07.003 17692399 (Pubitemid 47243683)
23. aroma-An R Object-oriented Microarray Analysis Environment. http://www.maths.lth.se/publications/
24. The R Project for Statistical Computing. http://www.r-project.org/
25. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, DeRisi JL, PLoS Biol 2003 1 5 12929205
26. Significance analysis of microarrays applied to the ionizing radiation response. Tusher VG, Tibshirani R, Chu G, Proc Natl Acad Sci USA 2001 98 5116 5121 10.1073/pnas.091062498 11309499 (Pubitemid 32397092)
27. Statistical significance for genomewide studies. Storey JD, Tibshirani R, Proc Natl Acad Sci USA 2003 100 9440 9445 10.1073/pnas.1530509100 12883005 (Pubitemid 37033947)
28. NeatMap - non-clustering heat map alternatives in R. Rajaram S, Oono Y, BMC Bioinformatics 2010 11 45 10.1186/1471-2105-11-45 20096121
29. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Zheng Q, Wang XJ, Nucleic Acids Res 2008 36 358 363 10.1093/nar/gkn276 18487275
30. Monte Carlo: concepts, algorithms, and applications, Corr. Fishman GS, New York: Springer 2 1997
31. Genome-wide compensatory changes accompany drug- selected mutations in the Plasmodium falciparum crt gene. Jiang H, Patel JJ, Yi M, Mu J, Ding J, Stephens R, Cooper RA, Ferdig MT, Su XZ, PLoS One 2008 3 2484 10.1371/journal.pone.0002484 18575593
32. Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. Ramharter M, Kurth F, Schreier AC, Nemeth J, Glasenapp I, Belard S, Schlie M, Kammer J, Koumba PK, Cisse B, Mordmuller B, Lell B, Issifou S, Oeuvray C, Fleckenstein L, Kremsner PG, J Infect Dis 2008 198 911 919 10.1086/591096 18694333
33. Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria. Lee SJ, McGready R, Fernandez C, Stepniewska K, Paw MK, Viladpai-nguen SJ, Thwai KL, Villegas L, Singhasivanon P, Greenwood BM, White NJ, Nosten F, Eur J Clin Pharmacol 2008 64 987 992 10.1007/s00228-008-0500-z 18594802
34. Study on mechanisms of Pyrimethamine resistance in Plasmodium falciparum by microarray analysis. Ponmee N, PhD Thesis Mahidol University, Biochemistry 2006
35. Discovery of gene function by expression profiling of the malaria parasite life cycle. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, De La Vega P, Holder AA, Batalov S, Carucci DJ, Winzeler EA, Science 2003 301 1503 1508 10.1126/science.1087025 12893887 (Pubitemid 37128535)
36. A genetically hard-wired metabolic transcriptome in Plasmodium falciparum fails to mount protective responses to lethal antifolates. Ganesan K, Ponmee N, Jiang L, Fowble JW, White J, Kamchonwongpaisan S, Yuthavong Y, Wilairat P, Rathod PK, PLoS Pathog 2008 4 1000214 10.1371/journal.ppat.1000214 19023412
37. Co-inhibition of Plasmodium falciparum S-adenosylmethionine decarboxylase/ornithine decarboxylase reveals perturbation-specific compensatory mechanisms by transcriptome, proteome, and metabolome analyses. van Brummelen AC, Olszewski KL, Wilinski D, Llinas M, Louw AI, Birkholtz LM, J Biol Chem 2009 284 4635 4646 19073607
38. Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Brazas MD, Hancock RE, Drug Discov Today 2005 10 1245 1252 10.1016/S1359-6446(05)03566-X 16213417 (Pubitemid 41411435)
39. Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum. Hu G, Cabrera A, Kono M, Mok S, Chaal BK, Haase S, Engelberg K, Cheemadan S, Spielmann T, Preiser PR, Gilberger TW, Bozdech Z, Nat Biotechnol 2010 28 91 98 10.1038/nbt.1597 20037583
40. A systematic approach to understand the mechanism of action of the bisthiazolium compound T4 on the human malaria parasite, Plasmodium falciparum. Le Roch KG, Johnson JR, Ahiboh H, Chung DW, Prudhomme J, Plouffe D, Henson K, Zhou Y, Witola W, Yates JR, Mamoun CB, Winzeler EA, Vial H, BMC Genomics 2008 9 513 10.1186/1471-2164-9-513 18973684
41. The Plasmodium falciparum sexual development transcriptome: a microarray analysis using ontology-based pattern identification. Young JA, Fivelman QL, Blair PL, de la Vega P, Le Roch KG, Zhou Y, Carucci DJ, Baker DA, Winzeler EA, Mol Biochem Parasitol 2005 143 67 79 10.1016/j.molbiopara.2005.05.007 16005087 (Pubitemid 41039033)
42. Dynamic RNA profiling in Plasmodium falciparum synchronized blood stages exposed to lethal doses of artesunate. Natalang O, Bischoff E, Deplaine G, Proux C, Dillies MA, Sismeiro O, Guigon G, Bonnefoy S, Patarapotikul J, Mercereau-Puijalon O, Coppee JY, David PH, BMC Genomics 2008 9 388 10.1186/1471-2164-9-388 18706115
43. Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum. Hoppe HC, van Schalkwyk DA, Wiehart UI, Meredith SA, Egan J, Weber BW, Antimicrob Agents Chemother 2004 48 2370 2378 10.1128/AAC.48.7.2370-2378. 2004 15215083 (Pubitemid 38823399)
44. Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum. Roberts L, Egan TJ, Joiner KA, Hoppe HC, Antimicrob Agents Chemother 2008 52 1840 1842 10.1128/AAC.01478-07 18316523 (Pubitemid 351614682)
45. Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum. Surolia N, Padmanaban G, Proc Natl Acad Sci USA 1991 88 4786 4790 10.1073/pnas.88.11.4786 2052558 (Pubitemid 21914627)
46. A programmed cell death pathway in the malaria parasite Plasmodium falciparum has general features of mammalian apoptosis but is mediated by clan CA cysteine proteases. Ch'ng JH, Kotturi SR, Chong AG, Lear MJ, Tan KS, Cell Death Dis 2010 1 26 10.1038/cddis.2010.2 21364634
47. Plasmodium falciparum: genome wide perturbations in transcript profiles among mixed stage cultures after chloroquine treatment. Gunasekera AM, Myrick A, Le Roch K, Winzeler E, Wirth DF, Exp Parasitol 2007 117 87 92 10.1016/j.exppara.2007.03.001 17475254 (Pubitemid 47102295)
48. Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum. Cui L, Miao J, Eukaryot Cell 2010 9 1138 1149 10.1128/EC.00036-10 20453074
49. Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo. Qi J, Wang S, Liu G, Peng H, Wang J, Zhu Z, Yang C, Biochem Biophys Res Commun 2004 319 1124 1131 10.1016/j.bbrc.2004.05.099 15194484 (Pubitemid 38759528)
50. The relationship of physico-chemical properties and structure to the differential antiplasmodial activity of the cinchona alkaloids. Warhurst DC, Craig JC, Adagu IS, Meyer DJ, Lee SY, Malar J 2003 2 26 10.1186/1475-2875-2-26 14505493